PHARMALEX NORWAY AS

0661 OSLO

Finances

Share Ownership

Return on Equity

101,91 %

Current Ratio

1,39

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	28 671 000	22 935 000	14 094 000	12 644 000
Net Income	3 529 000	4 179 000	1 226 000	1 288 000
Total Assets	11 515 000	11 196 000	6 306 000	6 283 000
Total Equity	3 463 000	3 434 000	2 255 000	2 028 000

Income (NOK)	2022	2021	2020	2019
Revenue	28 671 000	22 935 000	14 094 000	12 644 000
Expenditure	24 001 000	17 469 000	12 414 000	10 954 000
Operating Profit	4 671 000	5 467 000	1 681 000	1 691 000
Financial Income	641 000	408 000	190 000	19 000
Financial Costs	776 000	516 000	298 000	59 000
Financial Balance	−135 000	−108 000	−108 000	−40 000
Earnings Before Tax	4 535 000	5 359 000	1 573 000	1 651 000
Tax	1 006 000	1 180 000	347 000	363 000
Net Income	3 529 000	4 179 000	1 226 000	1 288 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	327 000	274 000	279 000	307 000
Total Current Assets	11 188 000	10 922 000	6 027 000	5 976 000
Total Assets	11 515 000	11 196 000	6 306 000	6 283 000
Total Retained Equity	3 353 000	3 324 000	2 145 000	1 918 000
Total Equity	3 463 000	3 434 000	2 255 000	2 028 000
Total Long-Term Debt	0	0	0	1 000
Total Current Debt	8 052 000	7 762 000	4 051 000	4 254 000
Total Equity and Debt	11 515 000	11 196 000	6 306 000	6 283 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	28 671 000	22 935 000	14 094 000	12 644 000
Other Income	0	0	0	0
Revenue	28 671 000	22 935 000	14 094 000	12 644 000
Cost of Goods Sold	9 529 000	6 450 000	2 388 000	2 446 000
Salary Costs	12 446 000	9 624 000	7 958 000	6 414 000
Depreciation	63 000	32 000	30 000	7 000
Impairment	0	0	0	0
Expenditure	24 001 000	17 469 000	12 414 000	10 954 000
Operating Profit	4 671 000	5 467 000	1 681 000	1 691 000
Financial Income	641 000	408 000	190 000	19 000
Financial Costs	776 000	516 000	298 000	59 000
Financial Balance	−135 000	−108 000	−108 000	−40 000
Dividends	3 500 000	3 000 000	1 000 000	1 500 000
Net Income	3 529 000	4 179 000	1 226 000	1 288 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	232 000	229 000	226 000	225 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	95 000	45 000	53 000	83 000
Total Tangible Assets	95 000	45 000	53 000	83 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	327 000	274 000	279 000	307 000
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	2 806 000	5 227 000	3 132 000	4 541 000
Total Current Assets	11 188 000	10 922 000	6 027 000	5 976 000
Total Assets	11 515 000	11 196 000	6 306 000	6 283 000
Total Equity	3 463 000	3 434 000	2 255 000	2 028 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	0	1 000
Creditors	931 000	1 446 000	807 000	728 000
Unpaid Taxes	1 078 000	1 082 000	900 000	953 000
Dividends	3 500 000	3 000 000	1 000 000	1 500 000
Other Current Debt	1 533 000	1 051 000	996 000	715 000
Total Current Debt	8 052 000	7 762 000	4 051 000	4 254 000
Total Equity and Debt	11 515 000	11 196 000	6 306 000	6 283 000

Financial indicators	2022	2021	2020	2019
Return on Equity	101,91 %	121,69 %	54,37 %	63,51 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	16,29 %	23,84 %	11,93 %	13,37 %
Current Ratio	1,39	1,41	1,49	1,4
Quick Ratio	1,39	1,41	1,49	1,4
Equity Ratio	0,3	0,31	0,36	0,32
Gross Profit Margin	66,76 %	71,88 %	83,06 %	80,65 %